本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Viking Therapeutics, Inc.

28.72
-0.1550-0.54%
成交量:282.19萬
成交額:8,027.70萬
市值:32.25億
市盈率:-24.90
高:29.01
開:28.91
低:27.69
收:28.87
資料載入中...
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/30

關聯方擬減持公告

Form144 | Viking Therapeutics高管Greg Zante擬減持16136股,總價約92.2萬美元
2024/07/30

關聯方擬減持公告

Form144 | Viking Therapeutics高管Brian Lian擬減持115,859股,總價約667萬美元
2024/07/30

關聯方擬減持公告

Form144 | Viking Therapeutics高管Marianna Mancini擬減持18026股,總價約102.99萬美元
2024/07/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/25

重要事件披露

Form 8-K - Current report
2024/06/04

重要事件披露

Form 8-K - Current report
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/23

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments